Cystic Fibrosis Foundation expands partnership with Pfizer

11/20/2012 | Genetic Engineering & Biotechnology News

The Cystic Fibrosis Foundation committed up to $58 million over six years in a project with Pfizer to develop drugs targeting the Delta F508 genetic mutation associated with the disease. The CFF retains rights to any drug candidate Pfizer discovers but chooses not to develop.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC